Pergolide compared with bromocriptine in Parkinson's disease: A multicenter, crossover, controlled study-Reference-Cited by-同舟云学术

Pergolide compared with bromocriptine in Parkinson's disease: A multicenter, crossover, controlled study

Published:1994 Issue:4 Volume:9 Page:431-436
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Pezzoli G.,Martignoni E.,Pacchetti C.,Angeleri V. A.,Lamberti P.,Muratorio A.,Bonuccelli U.,De Mari M.,Foschi N.,Cossutta E.,Nicoletti F.,Giammona F.,Canesi M.,Scarlato G.,Caraceni T.,Moscarelli E.

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference26 articles.

1. "On-off" phenomenon with levodopa therapy in parkinsonism: Clinical and pharmacologic correlations and the effect of intramuscular pyridoxine

2. "ON-OFF" EFFECTS IN PATIENTS WITH PARKINSON'S DISEASE ON CHRONIC LEVODOPA THERAPY

3. Contrast sensitivity in PD

4. Madopar HBS in fluctuating parkinsonian patients: Two-year treatment

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dopamine agonist therapy in Parkinson’s disease: Spanish expert consensus on its use in different clinical situations;Neurología (English Edition);2023-07

2. Restoring pars intermedia dopamine concentrations and tyrosine hydroxylase expression levels with pergolide: evidence from horses with pituitary pars intermedia dysfunction;BMC Veterinary Research;2020-09-25

3. A Stage-Based Approach to Therapy in Parkinson’s Disease;Biomolecules;2019-08-20

4. Tratamento inicial da doença de Parkinson;Revista Neurociências;2019-01-23

5. Tratamento inicial da doença de Parkinson.;Revista Neurociências;2019-01-23